Naslov
NOVEL ANTHRANILIC ACID DERIVATIVES AS PROMISING ANTI-TB AGENTS
(NOVEL ANTHRANILIC ACID DERIVATIVES AS PROMISING ANTI-TB AGENTS)

Autori
Beus, Maja ; Paulamäki, Lauri ; Savijoki, Krisi Savijoki ; Yli-Kauhaluoma, Jari ; Parikka, Mataleena ; Zorc, Branka

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
EFMC-ISMC Virtual 2021 Book of Abstracts / Altmann , Karl-Heinz ; Auberson, Yves P. - Online : European Federation for Medicinal Chemistry and Chemical Biology, 2021, 426-426

Skup
EFMC-ISMC International Syposium on Medicinal Chemistry

Mjesto i datum
Online, 29.08.2021. - 02.09.2021

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
tuberculosis ; chloroquine ; anthranilic acid
(tuberculosis ; chloroquine ; anthranilic acid ; quorum sensing)

Sažetak
Tuberculosis (TB) is still one of the top 10 causes of death, based on the WHO 2020 report (1), although much effort has been dedicated to the development of new anti-TB agents. After the discovery of bedaquilline, the quinoline heterocycle was recognized as a promising scaffold in search of new anti-TBC drugs. Inspired by this fact, our research team developed a new series of primaquine (PQ) derivatives showing high antitubercular activity (2). Additionally, a recent study involving 1280 fragment-library revealed a fragment from the anthranilic acid series as a lead to develop small molecules that inhibit Mycobacterium tuberculosis MabA activity (3). Bearing this in mind, we have synthesized 19 novel anthranilamides, hybrid compounds bearing chloroquine (CQ), PQ or harmine (HA) moiety in the amine part, and anthranilic derivatives in the carboxylic part of the molecule. The synthesis is outlined in the Scheme. The first step involved the coupling of PQ/CQ/HA with anthranilic acid moiety in the presence of HATU/DIEA or T3P/TEA and the second step was the removal of the protecting group. The Boc-protecting group was removed in the presence of TFA, whereas the benzyl group was removed by catalytic hydrogenation or with ammonium formate. The structures of novel compounds were confirmed by 1H and 13C NMR, IR, and MS spectroscopy. Antimycobacterial evaluation is in progress.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija

POVEZANOST RADA